436091-31-5

Usage

Uses

Used in Pharmaceutical Industry:
4-(1H-Benzimidazol-1-yl)butanoic acid is used as a building block for the synthesis of various pharmaceuticals. Its carboxylic acid group allows for the creation of ester, amide, and other organic compounds, which can be utilized in the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, 4-(1H-Benzimidazol-1-yl)butanoic acid is also used as a building block for the synthesis of various agrochemicals. Its structural versatility and pharmacological properties make it a promising candidate for the development of new agrochemicals with improved efficacy and selectivity.
Overall, 4-(1H-Benzimidazol-1-yl)butanoic acid's potential applications in both the pharmaceutical and agrochemical industries highlight its importance as a versatile chemical compound with a wide range of uses.

InChI:InChI=1/C11H12N2O2/c14-11(15)6-3-7-13-8-12-9-4-1-2-5-10(9)13/h1-2,4-5,8H,3,6-7H2,(H,14,15)

Upstream product

• 96-48-0 4-butanolide 
• 51-17-2 benzoimidazole 
• 796974-12-4 methyl 4-(1H-benzimidazol-1-yl)butanoate 
• 271-44-3 benzimidazole 
• 148245-19-6 1-(4-bromobutyl)-1H-benzo[d]imidazole 

Relevant academic research and scientific papers

Barton esters for initiator-free radical cyclisation with heteroaromatic substitution

S-(1-Oxido-2-pyridinyl)-1,1,3,3-tetramethylthiouronium hexafluorophosphate (HOTT) facilitates the first examples of efficient radical cyclisation with (hetero)aromatic substitution via Barton ester intermediates. Cyclopropyl and alkyl radicals allow acces

Preparation of 4-(azol-1-yl)butyric acids by the interaction of azoles with γ-butyrolactone

The interaction of salts of imidazole, 1,2,4-triazole, benzimidazole, and 2-benzylbenzimidazole with γ-butyrolactone has been studied. Ab initio quantum-chemical calculations showed a preference for N-alkylation on interaction of azolates with γ-butyrolac

Octahydro-2H-pyrido[1,2-a] pyrazine compounds

A compound selected from those of formula (I): 1wherein: Ra represents linear or branched (C1-C6)alkylene, X represents a group selected from W1, —C(W1)—W2—, —W2—C(W1)—, —W2—C(W1)W2—, —W2-Ra- and —CH(OR1)— wherein W1, W2 and R1 are as defined in the description, when Y represents aryl or heteroaryl, or X represents a group selected from single bond, —C(W1)—, —W2—C(W1)—, —W2-Ra and —CH(OR1)— wherein W1, W2, Ra and R1 are as defined hereinbefore, when Y represents a fused bicyclic group, of formula: 2?wherein: A represents nitrogen-containing heterocycle having from 4 to 7 ring members that is unsaturated or partially saturated and optionally contains a second hetero atom, B represents phenyl ring optionally substituted by one or more groups as defined in the description, its isomers, and addition salts thereof with a pharmaceutically acceptable acid or base, medicinal products containing the same are useful in the treatment of cognitive deficiencies.